iBio (IBIO) Change in Inventory (2016 - 2023)
iBio's (IBIO) quarterly Change in Inventory came in at -$43000.0 in Q1 2023, down 103.31% year-on-year from $1.3 million in Q1 2022, and up 45.57% on a QoQ basis from -$79000.0 in Q4 2022.
iBio (IBIO) Change in Inventory (2016 - 2023) Analysis & Trends
iBio (IBIO) has 6 years of Change in Inventory data on file, last reported at -$43000.0 in Q1 2023.
- On a quarterly basis, Change in Inventory fell 103.31% year-over-year to -$43000.0 in Q1 2023; TTM through Jun 2023 was $1.0 million, a 73.79% decrease from a year earlier, with the FY2023 full-year figure at $1.0 million, down 73.79% from the prior year.
- Change in Inventory for Q1 2023 stood at -$43000.0, up from -$79000.0 in the prior quarter.
- Over the last five years, Change in Inventory for IBIO reached as high as $1.4 million in Q4 2021 and fell as low as -$639000.0 in Q1 2021.
- Historically, Change in Inventory has averaged $374181.8 across 4 years, with a median of $228000.0 in 2020.
- Across the five-year window, Change in Inventory surged 1144.44% in 2021 and tumbled 105.65% in 2022, its largest moves.
- Year by year, Change in Inventory stood at $228000.0 in 2020, then surged by 513.6% to $1.4 million in 2021, then sank by 105.65% to -$79000.0 in 2022, then surged by 45.57% to -$43000.0 in 2023.
- Per Business Quant data, the three most recent Change in Inventory figures were -$43000.0 in Q1 2023, -$79000.0 in Q4 2022, and $1.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | 3.32 Mn |
| 10 | iBio | 166.24 Mn | 166.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -43,000.00 |
| Mar 31, 2023 | -43,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Sep 30, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 616,000.00 |
| Jun 30, 2022 | 616,000.00 |
| Mar 31, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 560,000.00 |
| Sep 30, 2021 | 560,000.00 |
| Jun 30, 2021 | -406,000.00 |
| Jun 30, 2021 | -406,000.00 |
| Mar 31, 2021 | -639,000.00 |
| Mar 31, 2021 | -639,000.00 |
| Dec 31, 2020 | 228,000.00 |
| Dec 31, 2020 | 228,000.00 |